Wednesday, May 19, 2021 12:49:54 PM
Since RGBP started-out boldly by focusing on Stem Cells and the mRNA, they must have substantial Patents in both areas? I think both those basic systems have a long way to go yet, and RGBP has a head start over just about any other Pharma' Co'? Yes, the big Pharma'l Co's have embarked on both roads to some extent, but their expertise lies in the old fashioned methods for the most part, as they are what got them here in the first place?
RGBP has developed some remarkable therapies and systems in those "NEW" areas, and is now showing signs of Co' interest by many Pharma Co's? Go RGBP!!!! GLTA holders!!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM